How can stem cell therapy help with dementia?

MSC therapy reduces neuroinflammation, promotes the growth of new neural connections, protects existing neurons from further damage, and may improve blood flow to the brain. These mechanisms help slow cognitive decline.

Is stem cell therapy effective for Alzheimer's disease?

While not a cure, MSC therapy shows promise in slowing Alzheimer's progression. Clinical studies demonstrate improvements in cognitive scores, daily function, and quality of life in treated patients.

When should dementia patients consider stem cell therapy?

Early intervention yields the best results. Patients with mild to moderate cognitive decline typically respond better than those with advanced dementia. Our team evaluates each case individually.

What cognitive improvements can be expected?

Improvements may include better memory recall, improved attention and focus, enhanced verbal communication, better spatial awareness, and improved ability to perform daily activities. Results vary by individual and disease stage.

Stem Cell Therapy for Alzheimer's Disease: Research & Potential

Clinical research on stem cell therapy for Alzheimer's disease. How MSC treatment may reduce neuroinflammation, support cognitive function, and slow neurodegeneration.

The Neuroinflammation Target in Alzheimer's Disease

Alzheimer's disease is characterised by amyloid-β plaques, tau tangles, and progressive neuronal death — but neuroinflammation amplifies the cascade at every stage. Activated microglia release pro-inflammatory cytokines that accelerate synaptic loss and neurodegeneration. MSC therapy addresses this inflammatory driver: Wharton's jelly MSCs suppress microglial over-activation, promote M2 (anti-inflammatory) macrophage polarisation, secrete BDNF and NGF that support neuronal survival, and stimulate endogenous neurogenesis in the hippocampus. Intrathecal + IV dual-delivery achieves both systemic and CNS-targeted action.

What Clinical Outcomes Have Been Observed?

Published case series and early-phase trials report cognitive stabilisation or modest improvement in MMSE and MoCA scores in 40–60% of mild-to-moderate Alzheimer's patients treated with MSC therapy. ADAS-cog improvements and caregiver-reported functional gains are also documented. Outcomes are strongest in patients with mild cognitive impairment (MCI) or early-stage Alzheimer's, where significant neuronal reserve remains. Severely advanced Alzheimer's with extensive brain atrophy shows limited response.

Alzheimer's Treatment Protocol in Istanbul

StemCell Longevita's Alzheimer's programme delivers 100–200 million Wharton's jelly MSCs via combined intrathecal and IV infusion over 3 sessions. Treatment includes baseline cognitive assessment (MMSE, MoCA, ADAS-cog), neuroimaging review, and inflammatory biomarker panels. A comprehensive caregiver briefing and 12-month telemedicine follow-up with quarterly cognitive assessments are included in every programme.

Frequently Asked Questions

How can stem cell therapy help with dementia?: MSC therapy reduces neuroinflammation, promotes the growth of new neural connections, protects existing neurons from further damage, and may improve blood flow to the brain. These mechanisms help slow cognitive decline.
Is stem cell therapy effective for Alzheimer's disease?: While not a cure, MSC therapy shows promise in slowing Alzheimer's progression. Clinical studies demonstrate improvements in cognitive scores, daily function, and quality of life in treated patients.
When should dementia patients consider stem cell therapy?: Early intervention yields the best results. Patients with mild to moderate cognitive decline typically respond better than those with advanced dementia. Our team evaluates each case individually.
What cognitive improvements can be expected?: Improvements may include better memory recall, improved attention and focus, enhanced verbal communication, better spatial awareness, and improved ability to perform daily activities. Results vary by individual and disease stage.

Stem Cell Therapy for Alzheimer's Disease: Research & Potential

The Neuroinflammation Target in Alzheimer's Disease

What Clinical Outcomes Have Been Observed?

Alzheimer's Treatment Protocol in Istanbul

Frequently Asked Questions

Transform Your Health with Regenerative Medicine in Istanbul